The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance
Tóm tắt
NF-E2–related factor 2 (Nrf2) transcription factor regulates a range of cytoprotective transcriptional responses, preventing further cellular injury by removing biochemical damage and renewing tissue. Here we show that acute myeloid leukemia (AML) cells possess greater constitutive nuclear levels of Nrf2 than normal control CD34+ cells because of an imbalance between mRNA expression levels of Nrf2 and its inhibitor Keap1 but not through their somatic mutation. Elevated Nrf2 was reduced by NF-κB inhibitors. Using promoter assays, ChIP and siRNA knockdown, we demonstrated NF-κB subunits p50 and p65 induce transcription of Nrf2 in AML cells at a specific promoter κB-site and that long-term lentiviral miRNA-knockdown of Nrf2 significantly reduced clonogenicity of AML patient cells and improved their chemotherapeutic responsiveness. Normal physiologic Nrf2 protects cells from damage, but here we have exposed aberrant continuous nuclear activation of Nrf2 in AML that allows cell survival, even against cytotoxic chemotherapeutics. We show for the first time that Nrf2, an important regulator of several biologic processes involved in the progression of cancer, has abnormal NF-κB–driven constitutive expression in AML. Such a mechanism allows for a greater cytoprotective response in human AML cells and encourages their evasion of chemotherapy-induced cytotoxicity, which is necessary for improved clinical outcomes.
Tài liệu tham khảo
Kvinlaug, 2011, Common and overlapping oncogenic pathways contribute to the evolution of acute myeloid leukemias., Cancer Res, 71, 4117, 10.1158/0008-5472.CAN-11-0176
Rushworth, 2011, High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitors., Cancer Res, 71, 1999, 10.1158/0008-5472.CAN-10-3018
Rushworth, 2008, HO-1 underlies resistance of AML cells to TNF-induced apoptosis., Blood, 111, 3793, 10.1182/blood-2007-07-104042
Pietsch, 2003, Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones., J Biol Chem, 278, 2361, 10.1074/jbc.M210664200
Shibata, 2008, Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer., Gastroenterology, 135, 1358, 10.1053/j.gastro.2008.06.082
Itoh, 1997, An Nrf2 small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements., Biochem Biophys Res Commun, 236, 313, 10.1006/bbrc.1997.6943
McMahon, 2003, Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression., J Biol Chem, 278, 21592, 10.1074/jbc.M300931200
Schäfer, 2010, Nrf2: a central regulator of UV protection in the epidermis., Cell Cycle, 9, 2917, 10.4161/cc.9.15.12701
Beyer, 2008, The cytoprotective Nrf2 transcription factor controls insulin receptor signaling in the regenerating liver., Cell Cycle, 7, 874, 10.4161/cc.7.7.5617
Beyer, 2008, Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance., EMBO J, 27, 212, 10.1038/sj.emboj.7601950
Heasman, 2011, Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1., Oncotarget, 2, 658, 10.18632/oncotarget.321
Lee, 2003, Identification of the NF-E2-related factor-2–dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis., J Biol Chem, 278, 12029, 10.1074/jbc.M211558200
Zhang, 2004, Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex., Mol Cell Biol, 24, 10941, 10.1128/MCB.24.24.10941-10953.2004
Bloom, 2003, Phosphorylation of Nrf2 at Ser(40) by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression., J Biol Chem, 278, 44675, 10.1074/jbc.M307633200
Dhakshinamoorthy, 2005, Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants., J Biol Chem, 280, 16891, 10.1074/jbc.M500166200
Reichard, 2007, Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1., Nucleic Acids Res, 35, 7074, 10.1093/nar/gkm638
Kim, 2008, Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells., Free Radic Biol Med, 45, 537, 10.1016/j.freeradbiomed.2008.05.011
Akhdar, 2009, Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells., Eur J Cancer, 45, 2219, 10.1016/j.ejca.2009.05.017
Zhang, 2010, Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth., Mol Cancer Ther, 9, 336, 10.1158/1535-7163.MCT-09-0589
Zaitseva, 2009, HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome., Retrovirology, 6, 11, 10.1186/1742-4690-6-11
Cordle, 1993, LPS induces phosphorylation of MAD3 activation of C-Rel and related NF-κB proteins in human monocytic THP-1 cells., J Biol Chem, 268, 11803, 10.1016/S0021-9258(19)50271-X
Rushworth, 2010, NF-κB–inhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction., Cancer Res, 70, 2973, 10.1158/0008-5472.CAN-09-3407
Rushworth, 2010, FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism., Oncotarget, 1, 359, 10.18632/oncotarget.168
DeNicola, 2011, Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis., Nature, 475, 106, 10.1038/nature10189
Bowen, 2005, RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years., Blood, 106, 2113, 10.1182/blood-2005-03-0867
Marzec, 2007, Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury., FASEB J, 21, 2237, 10.1096/fj.06-7759com
ENCODE Project Consortium, 2011, A user's guide to the encyclopedia of DNA elements (ENCODE)., PLoS Biol, 9, e1001046, 10.1371/journal.pbio.1001046
Rushworth, 2008, Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes., J Immunol, 181, 6730, 10.4049/jimmunol.181.10.6730
Ohta, 2008, Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth., Cancer Res, 68, 1303, 10.1158/0008-5472.CAN-07-5003
Kim, 2011, Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin., J Pathol, 220, 446, 10.1002/path.2653
Yamamoto, 2004, Identification of polymorphisms in the promoter region of the human NRF2 gene., Biochem Biophys Res Commun, 321, 72, 10.1016/j.bbrc.2004.06.112
Cho, 2002, Role of NRF2 in protection against hyperoxic lung injury in mice., Am J Respir Cell Mol Biol, 26, 175, 10.1165/ajrcmb.26.2.4501
Hope, 2004, Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity., Nat Immunol, 5, 738, 10.1038/ni1080
Rushworth, 2011, TNF mediates the sustained activation of Nrf2 in human monocytes., J Immunol, 187, 702, 10.4049/jimmunol.1004117
Grosjean-Raillard, 2009, ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia., Oncogene, 28, 1099, 10.1038/onc.2008.457
Grandage, 2005, P13-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways., Leukemia, 19, 586, 10.1038/sj.leu.2403653
Maher, 2008, Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid., Toxicol Sci, 106, 319, 10.1093/toxsci/kfn177
Chorley, 2012, Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha., Nucleic Acids Res, 40, 7416, 10.1093/nar/gks409
Reddy, 2008, Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling., Oncogene, 27, 5821, 10.1038/onc.2008.188